RINGPU(300119)
Search documents
动物保健板块1月23日跌0.32%,生物股份领跌,主力资金净流出1.42亿元
Zheng Xing Xing Ye Ri Bao· 2026-01-23 09:04
Market Overview - The animal health sector experienced a decline of 0.32% on January 23, with BioShares leading the drop [1] - The Shanghai Composite Index closed at 4136.16, up 0.33%, while the Shenzhen Component Index closed at 14439.66, up 0.79% [1] Stock Performance - Notable gainers in the animal health sector included: - Qudongli (920275) with a closing price of 9.68, up 4.09% on a trading volume of 36,300 shares and a turnover of 34.72 million yuan [1] - Haili Biological (603718) closed at 6.55, up 1.24% with a trading volume of 95,100 shares and a turnover of 61.91 million yuan [1] - Deyu Biological (920970) closed at 8.44, up 1.20% with a trading volume of 19,200 shares and a turnover of 16.26 million yuan [1] - Conversely, BioShares (600201) closed at 17.35, down 1.42% with a trading volume of 315,700 shares and a turnover of 551 million yuan [2] Capital Flow - The animal health sector saw a net outflow of 142 million yuan from institutional investors, while retail investors experienced a net inflow of 124 million yuan [2][3] - Specific stock capital flows included: - Zhongmu Shares (600195) with a net inflow of 14.27 million yuan from institutional investors [3] - Qudongli (920275) had a net inflow of 2.44 million yuan from retail investors [3] - Deyu Biological (920970) faced a net outflow of 1.04 million yuan from institutional investors [3]
瑞普生物:截至2026年1月20日,公司股东总户数为25567户
Zheng Quan Ri Bao Wang· 2026-01-22 12:13
证券日报网讯1月22日,瑞普生物(300119)在互动平台回答投资者提问时表示,截至2026年1月20日, 公司股东总户数为25567户。 ...
瑞普生物:公司将持续深耕该领域,丰富产品矩阵
Zheng Quan Ri Bao Wang· 2026-01-22 12:13
证券日报网讯1月22日,瑞普生物(300119)在互动平台回答投资者提问时表示,未来公司将持续深耕 该领域,丰富产品矩阵,为宠物提供更多优质的健康解决方案。 ...
瑞普生物:公司应收账款按与客户签订的合同约定回款期推进回款工作
Zheng Quan Ri Bao· 2026-01-22 11:45
证券日报网讯 1月22日,瑞普生物在互动平台回答投资者提问时表示,公司应收账款按与客户签订的合 同约定回款期推进回款工作,公司已严格按照账龄分析法及单项认定法计提坏账准备,相关财务处理符 合企业会计准则要求,充分考虑了回款相关风险。具体情况请关注公司后续披露的定期报告。 (文章来源:证券日报) ...
瑞普生物:喵干素为重组猫干扰素ω(冻干型),主要用于猫疱疹病毒感染的治疗
Zheng Quan Ri Bao Wang· 2026-01-22 11:41
证券日报网讯1月22日,瑞普生物(300119)在互动平台回答投资者提问时表示,喵干素为重组猫干扰 素ω(冻干型),其主要成分为重组猫干扰素ω蛋白,主要用于猫疱疹病毒感染的治疗,可提升猫咪的抗感 染能力,属于兽用生物制品。 ...
动物保健板块1月22日涨0.54%,贤丰控股领涨,主力资金净流入7379.41万元
Zheng Xing Xing Ye Ri Bao· 2026-01-22 08:48
Core Viewpoint - The animal health sector experienced a slight increase of 0.54% on January 22, with Xianfeng Holdings leading the gains. The Shanghai Composite Index rose by 0.14% to close at 4122.58, while the Shenzhen Component Index increased by 0.5% to 14327.05 [1]. Group 1: Stock Performance - Xianfeng Holdings (002141) closed at 4.19, up 9.97% with a trading volume of 720,300 shares and a transaction value of 297 million yuan [1]. - Other notable performers include Biological Shares (600201) at 17.60, up 1.79%, and Zhongmu Shares (600195) at 8.54, also up 1.79% [1]. - The overall trading volume and transaction values for various stocks in the animal health sector indicate active market participation [1]. Group 2: Capital Flow - The animal health sector saw a net inflow of 73.79 million yuan from institutional investors, while retail investors experienced a net outflow of 27.83 million yuan [2]. - The main capital inflow was primarily directed towards Xianfeng Holdings, which attracted 121 million yuan from institutional investors, representing 40.71% of its trading volume [3]. - Other stocks like Jinhe Biological (002688) and *ST Green Health (002868) also saw varying degrees of net inflow and outflow from different investor categories [3].
瑞普生物:公司2025年度报告已预约2026年3月31日披露
Mei Ri Jing Ji Xin Wen· 2026-01-22 08:02
(文章来源:每日经济新闻) 每经AI快讯,有投资者在投资者互动平台提问:公司年报预告什么时候公示? 瑞普生物(300119.SZ)1月22日在投资者互动平台表示,公司2025年度报告已预约2026年3月31日披 露,相关信息请以公司后续在深交所官网、巨潮资讯网发布的正式公告为准。 ...
瑞普生物:公司已推出氨糖软骨素、角鲨烯辅酶 Q10等多款宠物营养保健品
Mei Ri Jing Ji Xin Wen· 2026-01-22 07:29
(文章来源:每日经济新闻) 每经AI快讯,有投资者在投资者互动平台提问:现在家庭对宠物陪伴特别看重,贵公司是否会推出一 些宠物保健品或者营养品,提升宠物的体质健康和营养均衡。 瑞普生物(300119.SZ)1月22日在投资者互动平台表示,公司已推出氨糖软骨素、角鲨烯辅酶 Q10等多 款宠物营养保健品,26年即将上市磷虾鱼油、益生菌等产品,可助力宠物体质提升与营养均衡,契合养 宠家庭的宠物健康养护需求。未来公司将持续深耕该领域,丰富产品矩阵,为宠物提供更多优质的健康 解决方案。 ...
动物保健板块1月21日跌0.65%,回盛生物领跌,主力资金净流入969.35万元
Zheng Xing Xing Ye Ri Bao· 2026-01-21 08:48
Core Viewpoint - The animal health sector experienced a decline of 0.65% on January 21, with Huisheng Biological leading the drop. The Shanghai Composite Index rose by 0.08%, while the Shenzhen Component Index increased by 0.7 [1] Group 1: Stock Performance - The closing prices and performance of key stocks in the animal health sector showed varied results, with Shunlian Biological up by 4.20% and Huisheng Biological down by 6.19% [1][2] - The trading volume for Huisheng Biological was 419,900 shares, with a transaction value of 1.192 billion yuan, indicating significant market activity despite the decline [2] Group 2: Capital Flow - The animal health sector saw a net inflow of 9.6935 million yuan from institutional investors, while retail investors experienced a net outflow of 73.8174 million yuan, suggesting a shift in investor sentiment [2][3] - Among individual stocks, Xianfeng Holdings had a net inflow of 15.1182 million yuan from institutional investors, while Huisheng Biological saw a net outflow of 42.2249 million yuan from retail investors [3]
一文读懂中国宠物经济地图|这些地方搞定了1.2亿“毛孩子”的幸福生活
Nan Fang Nong Cun Bao· 2026-01-20 10:02
Core Insights - The pet economy in China is rapidly expanding, with the market expected to exceed 811.4 billion yuan by 2025, and the urban pet population reaching 120 million [2][6]. Group 1: Industry Overview - The pet economy has evolved from mere companionship to a lifestyle, creating a vast ecosystem around the entire lifecycle of pets [5][6]. - The geographical distribution and specialization within the pet industry have developed into a national framework, with significant contributions from various regions [6][7]. Group 2: Regional Highlights - Liaoning Anshan is emerging as a major hub for pet breeding, supplying over 60% of the national pet dog and cat population, with an industry scale exceeding 10 billion yuan [18][19][20]. - Hebei and Shandong are recognized as the primary pet food production areas, with a projected 14% increase in pet food shipment volume by 2025 [30][31]. - The Yangtze River Delta is positioned as the "universe center" for pet supplies, leveraging its supply chain advantages and manufacturing capabilities [49][50]. Group 3: Emerging Trends - The pet vaccine sector is witnessing significant growth, with companies like Princely and Jinhe Bio reporting substantial revenue increases, indicating a burgeoning market for pet health products [78][86]. - The smart pet products market is projected to surpass 10.2 billion yuan, driven by advancements in AI and e-commerce integration [91][92]. - The "pet+" trend is gaining traction, with services like pet transportation and photography experiencing exponential growth, reflecting a shift towards emotional spending in pet ownership [106][108]. Group 4: Infrastructure and Services - Guangzhou Baiyun Airport has become the first pet-friendly airport in China, facilitating easier travel for pet owners [120][129]. - The development of pet-friendly cities and services is on the rise, enhancing the overall experience for pet owners and their pets [116][118].